Stock CYTH CYCLO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Cyclo Therapeutics, Inc.

Equities

CYTH

US23254X2018

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-03 EDT 		5-day change 1st Jan Change
1.29 USD +0.78% Intraday chart for Cyclo Therapeutics, Inc. -4.44% -18.87%
05-30 Cyclo Therapeutics, Inc. Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC Trial of Niemann-Pick Type C1 CI
05-24 Cyclo Therapeutics Files $100 Million Mixed Shelf MT

Chart calendar Cyclo Therapeutics, Inc.

eb70fdc1802a1028a10e3e.tcc1Q8IHhdfHhyYTMj6lnp38fhVpbRVb8jKslYaObjE.1rVvdptJw4OeyVV6flj63dqZSW0bQGUOgnTg2tHtX2DC8FY7u3-z4bXDUQ~a6a6dce646edb3eee94de828ca118174

Upcoming events on Cyclo Therapeutics, Inc.

2024-08-12 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-03-16 Q4 2024 Earnings Release (Projected)
2025-05-13 Q1 2025 Earnings Release (Projected)

Past events on Cyclo Therapeutics, Inc.

2024-05-15 Q1 2024 Earnings Release
2024-03-18 09:05 Q4 2023 Earnings Release
2024-03-16 Roth Conference
2023-12-25 Extraordinary Shareholders Meeting
2023-11-15 08:05 Q3 2023 Earnings Release
2023-10-12 12:00 Dawson James Small Cap Growth Conference
2023-03-20 08:05 Q4 2022 Earnings Release
2023-03-19 21:00 Society for Inherited Metabolic Disorders Meeting - Poster Number: 84
2023-01-19 11:00 Virtual Investor Companies to Watch Event
2022-11-11 08:05 Q3 2022 Earnings Release
2022-10-05 NPUK Family Conference
2022-09-12 07:00 H.C. Wainwright Global Investment Conference
2022-08-16 08:05 Interim 2022 Earnings Release
2022-07-30 13:30 NNPDF Family Support & Medical Conference - Trappsol Cyclo
2022-07-13 15:45 World Orphan Drug Congress
2022-06-23 20:35 Australian NPC Disease Foundation Conference
2022-05-24 07:00 H.C. Wainwright Global Life Sciences Investment Conference
2022-05-16 14:00 Investor Meeting
2022-05-12 16:05 Q1 2022 Earnings Release
2022-04-05 13:00 Investor Meeting - Key Opinion Leader

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		1,01
1,03
-2.12%		0,90
1,01
-10.38%		1,59
1,37
15.58%		1,38
2,38
-42.17%		1,08
0,58
85.91%
1,35

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-7,54
-6,59
-14.57%		-8,96
-7,61
-17.84%		-14,3
-16,2
12.02%		-15,6
-15,6
0.11%		-20,1
-19,9
-0.64%
-21,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,53
-6,57
-14.6%		-8,94
-7,59
-17.85%		-14,3
-16,2
12.02%		-15,5
-15,6
1.2%		-20,1
-19,9
-0.65%
-21,2

Net income
Million USD		Released
Forecast
Spread 		-7,53
-6,57
-14.6%		-8,94
-7,59
-17.85%		-14,3
-16,2
12.02%		-15,5
-15,6
1.2%		-20,1
-19,9
-0.65%
-21,2

EPS
USD		Released
Forecast
Spread 		-7,00
-6,00
-16.67%		-5,60
-3,74
-49.73%		-2,24
-2,46
8.94%		-1,83
-1,41
-29.79%		-1,23
-1,12
-9.82%
-0,68

Announcement Date30/03/2012/03/2111/03/2217/03/2318/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,19
0,55
-64.37%		0,54
0,57
-5.1%		0,45
0,62
-26.83%		0,19
0,64
-70.9%		0,15
0,38
-59.89%		0,12
0,18
-36%		0,50
0,14
251.4%		0,31
0,17
84.26%		0,20
0,38
-46.25%
0,10


0,47


0,37


0,30


0,25

EBIT
Million USD		Released
Forecast
Spread 		-2,93
-3,92
25.18%		-3,46
-4,09
15.56%		-4,25
-4,43
4.18%		-4,98
-4,79
-4.11%		-5,01
-4,70
-6.49%		-4,63
-5,36
13.58%		-4,77
-4,95
3.75%		-5,64
-5,33
-5.84%		-5,12
-5,34
4.18%
-5,00


-5,32


-6,28


-5,50


-5,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-2,77
-3,92
29.33%		-3,45
-4,09
15.66%		-4,25
-4,43
4.22%		-4,98
-4,79
-4.06%		-5,01
-4,70
-6.49%		-4,64
-5,36
13.52%		-4,77
-4,95
3.67%		-5,64
-5,33
-5.84%		-4,34
-5,34
18.74%
-5,00


-5,32


-6,28


-5,30


-5,40

Net income
Million USD		Released
Forecast
Spread 		-2,77
-3,92
29.33%		-3,45
-4,09
15.66%		-4,25
-4,43
4.22%		-4,98
-4,79
-4.06%		-5,01
-4,70
-6.49%		-4,64
-5,36
13.52%		-4,77
-4,95
3.67%		-5,64
-5,33
-5.84%		-4,34
-5,34
18.74%
-5,00


-5,32


-6,28


-5,30


-5,40

EPS
USD		Released
Forecast
Spread 		-0,33
-0,47
29.79%		-0,41
-0,49
16.33%		-0,50
-0,53
5.66%		-0,59
-0,25
-136%		-0,46
-0,42
-9.52%		-0,33
-0,49
32.65%		-0,29
-0,27
-7.41%		-0,23
-0,21
-9.52%		-0,15
-0,19
22.41%
-0,16


-0,17


-0,20


-0,16


-0,16

Announcement Date12/05/2215/08/2210/11/2217/03/2312/05/2314/08/2314/11/2318/03/2415/05/24-----

Upcoming sector events for Cyclo Therapeutics, Inc.

2024-07-03 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release (Projected)
2024-07-15 JOHNSON & JOHNSON: Q2 2024 Earnings Release (Projected)
2024-07-15 CAMURUS AB: Q2 2024 Earnings Release
2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 NOVARTIS AG: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Cyclo Therapeutics, Inc.

2024-05-30 08:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-30 07:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
2024-05-30 02:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 08:00 FDC LIMITED: Q4 2024 Earnings Release
2024-05-29 05:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
2024-05-29 04:44 ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-29 04:10 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-28 PFIZER LIMITED: Q4 2024 Earnings Release
2024-05-27 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
2024-05-27 08:10 ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CYTH Stock
  4. Calendar Cyclo Therapeutics, Inc.